nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—KCNH2—Quinidine barbiturate—malaria	0.0594	0.0907	CbGbCtD
Carvedilol—KCNH2—Quinine—malaria	0.0403	0.0617	CbGbCtD
Carvedilol—CYP2E1—Sulfadiazine—malaria	0.0387	0.0591	CbGbCtD
Carvedilol—KCNH2—Quinidine—malaria	0.0355	0.0542	CbGbCtD
Carvedilol—CYP2E1—Proguanil—malaria	0.0309	0.0472	CbGbCtD
Carvedilol—CYP1A1—Quinine—malaria	0.0258	0.0394	CbGbCtD
Carvedilol—CYP1A1—Quinidine—malaria	0.0227	0.0346	CbGbCtD
Carvedilol—CYP3A4—Clindamycin—malaria	0.0204	0.0312	CbGbCtD
Carvedilol—CYP2C9—Sulfadiazine—malaria	0.0201	0.0308	CbGbCtD
Carvedilol—CYP2C9—Pyrimethamine—malaria	0.0201	0.0308	CbGbCtD
Carvedilol—CYP2E1—Quinine—malaria	0.0199	0.0304	CbGbCtD
Carvedilol—PTGS1—Dapsone—malaria	0.0195	0.0299	CbGbCtD
Carvedilol—CYP2D6—Pyrimethamine—malaria	0.0184	0.0282	CbGbCtD
Carvedilol—CYP1A2—Proguanil—malaria	0.0179	0.0273	CbGbCtD
Carvedilol—CYP2E1—Quinidine—malaria	0.0175	0.0268	CbGbCtD
Carvedilol—CYP2C9—Artemether—malaria	0.0171	0.0262	CbGbCtD
Carvedilol—CYP2C9—Proguanil—malaria	0.0161	0.0246	CbGbCtD
Carvedilol—CYP2D6—Artemether—malaria	0.0157	0.0239	CbGbCtD
Carvedilol—CYP2E1—Dapsone—malaria	0.0151	0.0231	CbGbCtD
Carvedilol—CYP2D6—Proguanil—malaria	0.0147	0.0225	CbGbCtD
Carvedilol—CYP2D6—Quinidine barbiturate—malaria	0.014	0.0213	CbGbCtD
Carvedilol—CYP1A2—Pentoxifylline—malaria	0.0128	0.0196	CbGbCtD
Carvedilol—CYP3A4—Sulfadiazine—malaria	0.0117	0.0179	CbGbCtD
Carvedilol—CYP1A2—Quinine—malaria	0.0115	0.0176	CbGbCtD
Carvedilol—CYP2C9—Quinine—malaria	0.0104	0.0159	CbGbCtD
Carvedilol—CYP1A2—Quinidine—malaria	0.0101	0.0155	CbGbCtD
Carvedilol—ABCB1—Quinine—malaria	0.0101	0.0154	CbGbCtD
Carvedilol—CYP3A4—Artemether—malaria	0.00996	0.0152	CbGbCtD
Carvedilol—CYP2D6—Quinine—malaria	0.00949	0.0145	CbGbCtD
Carvedilol—CYP3A4—Proguanil—malaria	0.00936	0.0143	CbGbCtD
Carvedilol—CYP2C9—Quinidine—malaria	0.00912	0.0139	CbGbCtD
Carvedilol—CYP3A4—Doxycycline—malaria	0.00888	0.0136	CbGbCtD
Carvedilol—ABCB1—Quinidine—malaria	0.00885	0.0135	CbGbCtD
Carvedilol—CYP2D6—Quinidine—malaria	0.00834	0.0127	CbGbCtD
Carvedilol—CYP2C9—Dapsone—malaria	0.00787	0.012	CbGbCtD
Carvedilol—CYP3A4—Quinine—malaria	0.00603	0.00922	CbGbCtD
Carvedilol—NPPB—blood plasma—malaria	0.00536	0.0499	CbGeAlD
Carvedilol—CYP3A4—Quinidine—malaria	0.0053	0.00811	CbGbCtD
Carvedilol—CYP3A4—Dapsone—malaria	0.00457	0.00699	CbGbCtD
Carvedilol—SELE—endothelium—malaria	0.00407	0.0379	CbGeAlD
Carvedilol—GJA1—Caffeine—Pentoxifylline—malaria	0.00376	1	CbGdCrCtD
Carvedilol—VCAM1—endothelium—malaria	0.00375	0.0349	CbGeAlD
Carvedilol—SELE—blood plasma—malaria	0.00362	0.0337	CbGeAlD
Carvedilol—HIF1A—endothelium—malaria	0.0036	0.0336	CbGeAlD
Carvedilol—GJA1—endothelium—malaria	0.0035	0.0326	CbGeAlD
Carvedilol—VCAM1—blood plasma—malaria	0.00333	0.031	CbGeAlD
Carvedilol—NPPB—hematopoietic system—malaria	0.00296	0.0276	CbGeAlD
Carvedilol—SELE—saliva-secreting gland—malaria	0.0021	0.0195	CbGeAlD
Carvedilol—SELE—hematopoietic system—malaria	0.002	0.0186	CbGeAlD
Carvedilol—NPPB—blood—malaria	0.00196	0.0183	CbGeAlD
Carvedilol—VCAM1—saliva-secreting gland—malaria	0.00193	0.0179	CbGeAlD
Carvedilol—HIF1A—saliva-secreting gland—malaria	0.00186	0.0173	CbGeAlD
Carvedilol—VCAM1—hematopoietic system—malaria	0.00184	0.0171	CbGeAlD
Carvedilol—GJA1—saliva-secreting gland—malaria	0.0018	0.0168	CbGeAlD
Carvedilol—HIF1A—hematopoietic system—malaria	0.00177	0.0165	CbGeAlD
Carvedilol—GJA1—hematopoietic system—malaria	0.00172	0.016	CbGeAlD
Carvedilol—NDUFC2—saliva-secreting gland—malaria	0.00157	0.0146	CbGeAlD
Carvedilol—VCAM1—kidney—malaria	0.00151	0.014	CbGeAlD
Carvedilol—NDUFC2—hematopoietic system—malaria	0.00149	0.0139	CbGeAlD
Carvedilol—HIF1A—kidney—malaria	0.00145	0.0135	CbGeAlD
Carvedilol—GJA1—kidney—malaria	0.00141	0.0131	CbGeAlD
Carvedilol—SELE—digestive system—malaria	0.00139	0.0129	CbGeAlD
Carvedilol—SELE—blood—malaria	0.00133	0.0123	CbGeAlD
Carvedilol—VCAM1—digestive system—malaria	0.00128	0.0119	CbGeAlD
Carvedilol—HIF1A—digestive system—malaria	0.00123	0.0115	CbGeAlD
Carvedilol—NDUFC2—kidney—malaria	0.00123	0.0114	CbGeAlD
Carvedilol—VCAM1—blood—malaria	0.00122	0.0113	CbGeAlD
Carvedilol—NPPB—brain—malaria	0.00122	0.0113	CbGeAlD
Carvedilol—GJA1—digestive system—malaria	0.00119	0.0111	CbGeAlD
Carvedilol—VCAM1—bone marrow—malaria	0.00118	0.011	CbGeAlD
Carvedilol—HIF1A—blood—malaria	0.00117	0.0109	CbGeAlD
Carvedilol—HIF1A—bone marrow—malaria	0.00113	0.0106	CbGeAlD
Carvedilol—GJA1—bone marrow—malaria	0.0011	0.0102	CbGeAlD
Carvedilol—NDUFC2—digestive system—malaria	0.00104	0.00968	CbGeAlD
Carvedilol—SELE—liver—malaria	0.00104	0.00965	CbGeAlD
Carvedilol—NDUFC2—blood—malaria	0.00099	0.00922	CbGeAlD
Carvedilol—XDH—kidney—malaria	0.000989	0.00921	CbGeAlD
Carvedilol—NDUFC2—bone marrow—malaria	0.000958	0.00892	CbGeAlD
Carvedilol—VCAM1—liver—malaria	0.000953	0.00887	CbGeAlD
Carvedilol—HIF1A—liver—malaria	0.000917	0.00854	CbGeAlD
Carvedilol—GJA1—liver—malaria	0.00089	0.00828	CbGeAlD
Carvedilol—VEGFA—bone marrow—malaria	0.000869	0.00809	CbGeAlD
Carvedilol—XDH—digestive system—malaria	0.000839	0.00781	CbGeAlD
Carvedilol—SELE—brain—malaria	0.000822	0.00766	CbGeAlD
Carvedilol—NDUFC2—liver—malaria	0.000774	0.00721	CbGeAlD
Carvedilol—CYP1A2—blood plasma—malaria	0.000761	0.00708	CbGeAlD
Carvedilol—VCAM1—brain—malaria	0.000756	0.00704	CbGeAlD
Carvedilol—PTGS1—endothelium—malaria	0.000742	0.00691	CbGeAlD
Carvedilol—ADRA1B—kidney—malaria	0.000742	0.00691	CbGeAlD
Carvedilol—HIF1A—brain—malaria	0.000728	0.00677	CbGeAlD
Carvedilol—CYP2C9—blood plasma—malaria	0.000722	0.00672	CbGeAlD
Carvedilol—GJA1—brain—malaria	0.000706	0.00657	CbGeAlD
Carvedilol—VEGFA—liver—malaria	0.000703	0.00654	CbGeAlD
Carvedilol—ADRA2A—blood plasma—malaria	0.0007	0.00651	CbGeAlD
Carvedilol—CYP2E1—blood plasma—malaria	0.000684	0.00637	CbGeAlD
Carvedilol—PTGS1—blood plasma—malaria	0.000659	0.00614	CbGeAlD
Carvedilol—XDH—liver—malaria	0.000625	0.00582	CbGeAlD
Carvedilol—NDUFC2—brain—malaria	0.000615	0.00572	CbGeAlD
Carvedilol—VEGFA—brain—malaria	0.000557	0.00519	CbGeAlD
Carvedilol—CYP3A4—blood plasma—malaria	0.000551	0.00513	CbGeAlD
Carvedilol—CYP2D6—blood plasma—malaria	0.000542	0.00505	CbGeAlD
Carvedilol—ADRA1A—hematopoietic system—malaria	0.000509	0.00474	CbGeAlD
Carvedilol—KCNH2—hematopoietic system—malaria	0.000491	0.00457	CbGeAlD
Carvedilol—CYP1A2—hematopoietic system—malaria	0.000421	0.00392	CbGeAlD
Carvedilol—CYP1A1—hematopoietic system—malaria	0.000415	0.00386	CbGeAlD
Carvedilol—CYP2C9—hematopoietic system—malaria	0.000399	0.00372	CbGeAlD
Carvedilol—ADRA2C—kidney—malaria	0.000397	0.0037	CbGeAlD
Carvedilol—ABCB1—blood plasma—malaria	0.00039	0.00363	CbGeAlD
Carvedilol—ADRA2A—hematopoietic system—malaria	0.000387	0.0036	CbGeAlD
Carvedilol—CYP2E1—hematopoietic system—malaria	0.000378	0.00352	CbGeAlD
Carvedilol—ADRA1B—brain—malaria	0.000372	0.00347	CbGeAlD
Carvedilol—PTGS1—hematopoietic system—malaria	0.000365	0.00339	CbGeAlD
Carvedilol—ADRA1D—brain—malaria	0.000364	0.00339	CbGeAlD
Carvedilol—CYP1A1—kidney—malaria	0.00034	0.00317	CbGeAlD
Carvedilol—ADRA1A—blood—malaria	0.000337	0.00314	CbGeAlD
Carvedilol—KCNH2—blood—malaria	0.000326	0.00303	CbGeAlD
Carvedilol—ADRA2C—blood—malaria	0.000321	0.00299	CbGeAlD
Carvedilol—KCNH2—bone marrow—malaria	0.000315	0.00293	CbGeAlD
Carvedilol—CYP2E1—kidney—malaria	0.00031	0.00289	CbGeAlD
Carvedilol—Immune system disorder—Quinine—malaria	0.000309	0.00208	CcSEcCtD
Carvedilol—Haemorrhage—Quinidine barbiturate—malaria	0.000309	0.00208	CcSEcCtD
Carvedilol—Mediastinal disorder—Quinidine—malaria	0.000308	0.00208	CcSEcCtD
Carvedilol—Mediastinal disorder—Quinine—malaria	0.000308	0.00208	CcSEcCtD
Carvedilol—Haemorrhage—Pentoxifylline—malaria	0.000308	0.00207	CcSEcCtD
Carvedilol—Urinary tract disorder—Quinidine barbiturate—malaria	0.000305	0.00205	CcSEcCtD
Carvedilol—CYP3A4—hematopoietic system—malaria	0.000305	0.00283	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000303	0.00204	CcSEcCtD
Carvedilol—Urethral disorder—Quinidine barbiturate—malaria	0.000302	0.00204	CcSEcCtD
Carvedilol—Insomnia—Sulfadiazine—malaria	0.000301	0.00203	CcSEcCtD
Carvedilol—CYP2D6—hematopoietic system—malaria	0.0003	0.00279	CbGeAlD
Carvedilol—Flatulence—Clindamycin—malaria	0.000299	0.00201	CcSEcCtD
Carvedilol—PTGS1—kidney—malaria	0.000299	0.00278	CbGeAlD
Carvedilol—Malnutrition—Quinidine—malaria	0.000298	0.002	CcSEcCtD
Carvedilol—Malnutrition—Quinine—malaria	0.000298	0.002	CcSEcCtD
Carvedilol—Nausea—Proguanil—malaria	0.000298	0.002	CcSEcCtD
Carvedilol—Visual impairment—Quinidine barbiturate—malaria	0.000297	0.002	CcSEcCtD
Carvedilol—Vision blurred—Dapsone—malaria	0.000296	0.00199	CcSEcCtD
Carvedilol—Back pain—Clindamycin—malaria	0.000293	0.00198	CcSEcCtD
Carvedilol—CYP1A2—digestive system—malaria	0.000293	0.00272	CbGeAlD
Carvedilol—Erythema multiforme—Quinidine barbiturate—malaria	0.000292	0.00197	CcSEcCtD
Carvedilol—Muscle spasms—Clindamycin—malaria	0.000292	0.00196	CcSEcCtD
Carvedilol—Decreased appetite—Sulfadiazine—malaria	0.000289	0.00195	CcSEcCtD
Carvedilol—CYP1A1—digestive system—malaria	0.000289	0.00269	CbGeAlD
Carvedilol—Tinnitus—Quinidine barbiturate—malaria	0.000288	0.00194	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Sulfadiazine—malaria	0.000287	0.00193	CcSEcCtD
Carvedilol—Vertigo—Dapsone—malaria	0.000282	0.0019	CcSEcCtD
Carvedilol—Vision blurred—Quinidine—malaria	0.000281	0.00189	CcSEcCtD
Carvedilol—Vision blurred—Quinine—malaria	0.000281	0.00189	CcSEcCtD
Carvedilol—Anaemia—Clindamycin—malaria	0.00028	0.00189	CcSEcCtD
Carvedilol—CYP1A2—blood—malaria	0.000279	0.00259	CbGeAlD
Carvedilol—Immune system disorder—Quinidine barbiturate—malaria	0.000279	0.00188	CcSEcCtD
Carvedilol—Immune system disorder—Pentoxifylline—malaria	0.000278	0.00187	CcSEcCtD
Carvedilol—Mediastinal disorder—Quinidine barbiturate—malaria	0.000278	0.00187	CcSEcCtD
Carvedilol—CYP2C9—digestive system—malaria	0.000278	0.00259	CbGeAlD
Carvedilol—CYP1A1—blood—malaria	0.000275	0.00256	CbGeAlD
Carvedilol—Cough—Dapsone—malaria	0.000274	0.00184	CcSEcCtD
Carvedilol—Vertigo—Clindamycin—malaria	0.000273	0.00184	CcSEcCtD
Carvedilol—Angioedema—Quinidine—malaria	0.000272	0.00183	CcSEcCtD
Carvedilol—Angioedema—Quinine—malaria	0.000272	0.00183	CcSEcCtD
Carvedilol—Gastrointestinal pain—Sulfadiazine—malaria	0.000272	0.00183	CcSEcCtD
Carvedilol—Leukopenia—Clindamycin—malaria	0.000272	0.00183	CcSEcCtD
Carvedilol—Malnutrition—Quinidine barbiturate—malaria	0.000269	0.00181	CcSEcCtD
Carvedilol—Vertigo—Quinidine—malaria	0.000267	0.0018	CcSEcCtD
Carvedilol—Vertigo—Quinine—malaria	0.000267	0.0018	CcSEcCtD
Carvedilol—Syncope—Quinidine—malaria	0.000267	0.0018	CcSEcCtD
Carvedilol—Syncope—Quinine—malaria	0.000267	0.0018	CcSEcCtD
Carvedilol—Leukopenia—Quinine—malaria	0.000266	0.00179	CcSEcCtD
Carvedilol—Leukopenia—Quinidine—malaria	0.000266	0.00179	CcSEcCtD
Carvedilol—CYP2C9—blood—malaria	0.000265	0.00246	CbGeAlD
Carvedilol—ADRB1—brain—malaria	0.000265	0.00246	CbGeAlD
Carvedilol—Flatulence—Pentoxifylline—malaria	0.000264	0.00178	CcSEcCtD
Carvedilol—Urticaria—Sulfadiazine—malaria	0.000264	0.00178	CcSEcCtD
Carvedilol—ADRA1A—liver—malaria	0.000264	0.00245	CbGeAlD
Carvedilol—Tension—Quinidine barbiturate—malaria	0.000264	0.00178	CcSEcCtD
Carvedilol—CYP2E1—digestive system—malaria	0.000263	0.00245	CbGeAlD
Carvedilol—Tension—Pentoxifylline—malaria	0.000263	0.00177	CcSEcCtD
Carvedilol—Palpitations—Quinine—malaria	0.000263	0.00177	CcSEcCtD
Carvedilol—Palpitations—Quinidine—malaria	0.000263	0.00177	CcSEcCtD
Carvedilol—Body temperature increased—Sulfadiazine—malaria	0.000263	0.00177	CcSEcCtD
Carvedilol—Abdominal pain—Sulfadiazine—malaria	0.000263	0.00177	CcSEcCtD
Carvedilol—Hypertension—Clindamycin—malaria	0.000262	0.00176	CcSEcCtD
Carvedilol—Loss of consciousness—Quinidine—malaria	0.000262	0.00176	CcSEcCtD
Carvedilol—Loss of consciousness—Quinine—malaria	0.000262	0.00176	CcSEcCtD
Carvedilol—Nervousness—Quinidine barbiturate—malaria	0.000261	0.00176	CcSEcCtD
Carvedilol—Nervousness—Pentoxifylline—malaria	0.00026	0.00175	CcSEcCtD
Carvedilol—Back pain—Pentoxifylline—malaria	0.000259	0.00175	CcSEcCtD
Carvedilol—Convulsion—Quinine—malaria	0.000258	0.00174	CcSEcCtD
Carvedilol—Convulsion—Quinidine—malaria	0.000258	0.00174	CcSEcCtD
Carvedilol—Muscle spasms—Pentoxifylline—malaria	0.000258	0.00174	CcSEcCtD
Carvedilol—ADRA2A—blood—malaria	0.000256	0.00239	CbGeAlD
Carvedilol—Discomfort—Clindamycin—malaria	0.000255	0.00172	CcSEcCtD
Carvedilol—PTGS1—digestive system—malaria	0.000254	0.00236	CbGeAlD
Carvedilol—Chest pain—Quinidine—malaria	0.000253	0.00171	CcSEcCtD
Carvedilol—Myalgia—Quinidine—malaria	0.000253	0.00171	CcSEcCtD
Carvedilol—Chest pain—Quinine—malaria	0.000253	0.00171	CcSEcCtD
Carvedilol—Myalgia—Quinine—malaria	0.000253	0.00171	CcSEcCtD
Carvedilol—Vision blurred—Quinidine barbiturate—malaria	0.000253	0.00171	CcSEcCtD
Carvedilol—Vision blurred—Pentoxifylline—malaria	0.000253	0.0017	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000252	0.00169	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000252	0.00169	CcSEcCtD
Carvedilol—ADRA2C—liver—malaria	0.000251	0.00234	CbGeAlD
Carvedilol—CYP2E1—blood—malaria	0.000251	0.00233	CbGeAlD
Carvedilol—Tachycardia—Dapsone—malaria	0.00025	0.00168	CcSEcCtD
Carvedilol—CYP3A4—kidney—malaria	0.00025	0.00232	CbGeAlD
Carvedilol—Ill-defined disorder—Pentoxifylline—malaria	0.000249	0.00168	CcSEcCtD
Carvedilol—Anaemia—Pentoxifylline—malaria	0.000248	0.00167	CcSEcCtD
Carvedilol—Anaphylactic shock—Clindamycin—malaria	0.000248	0.00167	CcSEcCtD
Carvedilol—CYP2D6—kidney—malaria	0.000246	0.00229	CbGeAlD
Carvedilol—Angioedema—Quinidine barbiturate—malaria	0.000245	0.00165	CcSEcCtD
Carvedilol—Angioedema—Pentoxifylline—malaria	0.000245	0.00165	CcSEcCtD
Carvedilol—Hypersensitivity—Sulfadiazine—malaria	0.000245	0.00165	CcSEcCtD
Carvedilol—Confusional state—Quinine—malaria	0.000245	0.00165	CcSEcCtD
Carvedilol—Confusional state—Quinidine—malaria	0.000245	0.00165	CcSEcCtD
Carvedilol—Oedema—Quinine—malaria	0.000243	0.00164	CcSEcCtD
Carvedilol—Oedema—Quinidine—malaria	0.000243	0.00164	CcSEcCtD
Carvedilol—Thrombocytopenia—Clindamycin—malaria	0.000242	0.00163	CcSEcCtD
Carvedilol—Malaise—Pentoxifylline—malaria	0.000242	0.00163	CcSEcCtD
Carvedilol—PTGS1—blood—malaria	0.000242	0.00225	CbGeAlD
Carvedilol—Vertigo—Quinidine barbiturate—malaria	0.000241	0.00163	CcSEcCtD
Carvedilol—Syncope—Quinidine barbiturate—malaria	0.000241	0.00162	CcSEcCtD
Carvedilol—Leukopenia—Quinidine barbiturate—malaria	0.00024	0.00162	CcSEcCtD
Carvedilol—Leukopenia—Pentoxifylline—malaria	0.00024	0.00162	CcSEcCtD
Carvedilol—Shock—Quinidine—malaria	0.000239	0.00161	CcSEcCtD
Carvedilol—Shock—Quinine—malaria	0.000239	0.00161	CcSEcCtD
Carvedilol—Thrombocytopenia—Quinidine—malaria	0.000238	0.0016	CcSEcCtD
Carvedilol—Thrombocytopenia—Quinine—malaria	0.000238	0.0016	CcSEcCtD
Carvedilol—Palpitations—Quinidine barbiturate—malaria	0.000237	0.0016	CcSEcCtD
Carvedilol—Tachycardia—Quinidine—malaria	0.000237	0.0016	CcSEcCtD
Carvedilol—Tachycardia—Quinine—malaria	0.000237	0.0016	CcSEcCtD
Carvedilol—Palpitations—Pentoxifylline—malaria	0.000237	0.0016	CcSEcCtD
Carvedilol—Loss of consciousness—Quinidine barbiturate—malaria	0.000236	0.00159	CcSEcCtD
Carvedilol—Skin disorder—Quinidine—malaria	0.000236	0.00159	CcSEcCtD
Carvedilol—Skin disorder—Quinine—malaria	0.000236	0.00159	CcSEcCtD
Carvedilol—Pruritus—Sulfadiazine—malaria	0.000235	0.00158	CcSEcCtD
Carvedilol—Hyperhidrosis—Quinidine—malaria	0.000235	0.00158	CcSEcCtD
Carvedilol—Hyperhidrosis—Quinine—malaria	0.000235	0.00158	CcSEcCtD
Carvedilol—Convulsion—Quinidine barbiturate—malaria	0.000233	0.00157	CcSEcCtD
Carvedilol—Convulsion—Pentoxifylline—malaria	0.000232	0.00156	CcSEcCtD
Carvedilol—Anorexia—Quinine—malaria	0.000232	0.00156	CcSEcCtD
Carvedilol—Anorexia—Quinidine—malaria	0.000232	0.00156	CcSEcCtD
Carvedilol—Insomnia—Dapsone—malaria	0.000232	0.00156	CcSEcCtD
Carvedilol—Hypertension—Pentoxifylline—malaria	0.000232	0.00156	CcSEcCtD
Carvedilol—Hypotension—Clindamycin—malaria	0.000231	0.00156	CcSEcCtD
Carvedilol—Arthralgia—Quinidine barbiturate—malaria	0.000229	0.00154	CcSEcCtD
Carvedilol—Myalgia—Quinidine barbiturate—malaria	0.000229	0.00154	CcSEcCtD
Carvedilol—Chest pain—Quinidine barbiturate—malaria	0.000229	0.00154	CcSEcCtD
Carvedilol—Chest pain—Pentoxifylline—malaria	0.000228	0.00154	CcSEcCtD
Carvedilol—Myalgia—Pentoxifylline—malaria	0.000228	0.00154	CcSEcCtD
Carvedilol—Diarrhoea—Sulfadiazine—malaria	0.000228	0.00153	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000227	0.00153	CcSEcCtD
Carvedilol—Hypotension—Quinine—malaria	0.000227	0.00153	CcSEcCtD
Carvedilol—Hypotension—Quinidine—malaria	0.000227	0.00153	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000227	0.00153	CcSEcCtD
Carvedilol—Discomfort—Pentoxifylline—malaria	0.000226	0.00152	CcSEcCtD
Carvedilol—Dry mouth—Pentoxifylline—malaria	0.000223	0.0015	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Quinidine—malaria	0.000221	0.00149	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Quinine—malaria	0.000221	0.00149	CcSEcCtD
Carvedilol—Confusional state—Quinidine barbiturate—malaria	0.000221	0.00149	CcSEcCtD
Carvedilol—Dyspnoea—Clindamycin—malaria	0.000221	0.00149	CcSEcCtD
Carvedilol—Confusional state—Pentoxifylline—malaria	0.000221	0.00149	CcSEcCtD
Carvedilol—Oedema—Quinidine barbiturate—malaria	0.000219	0.00148	CcSEcCtD
Carvedilol—Anaphylactic shock—Pentoxifylline—malaria	0.000219	0.00147	CcSEcCtD
Carvedilol—Oedema—Pentoxifylline—malaria	0.000219	0.00147	CcSEcCtD
Carvedilol—CYP1A2—liver—malaria	0.000218	0.00203	CbGeAlD
Carvedilol—Dyspepsia—Clindamycin—malaria	0.000218	0.00147	CcSEcCtD
Carvedilol—Infection—Pentoxifylline—malaria	0.000217	0.00146	CcSEcCtD
Carvedilol—Dyspnoea—Quinidine—malaria	0.000217	0.00146	CcSEcCtD
Carvedilol—Dyspnoea—Quinine—malaria	0.000217	0.00146	CcSEcCtD
Carvedilol—Shock—Quinidine barbiturate—malaria	0.000216	0.00145	CcSEcCtD
Carvedilol—ABCB1—hematopoietic system—malaria	0.000216	0.00201	CbGeAlD
Carvedilol—Shock—Pentoxifylline—malaria	0.000215	0.00145	CcSEcCtD
Carvedilol—CYP1A1—liver—malaria	0.000215	0.002	CbGeAlD
Carvedilol—Thrombocytopenia—Quinidine barbiturate—malaria	0.000215	0.00145	CcSEcCtD
Carvedilol—Thrombocytopenia—Pentoxifylline—malaria	0.000214	0.00144	CcSEcCtD
Carvedilol—Tachycardia—Quinidine barbiturate—malaria	0.000214	0.00144	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Clindamycin—malaria	0.000214	0.00144	CcSEcCtD
Carvedilol—Tachycardia—Pentoxifylline—malaria	0.000214	0.00144	CcSEcCtD
Carvedilol—Fatigue—Clindamycin—malaria	0.000213	0.00144	CcSEcCtD
Carvedilol—Skin disorder—Quinidine barbiturate—malaria	0.000213	0.00143	CcSEcCtD
Carvedilol—Skin disorder—Pentoxifylline—malaria	0.000213	0.00143	CcSEcCtD
Carvedilol—Hyperhidrosis—Quinidine barbiturate—malaria	0.000212	0.00143	CcSEcCtD
Carvedilol—CYP3A4—digestive system—malaria	0.000212	0.00197	CbGeAlD
Carvedilol—Constipation—Clindamycin—malaria	0.000212	0.00143	CcSEcCtD
Carvedilol—Pain—Clindamycin—malaria	0.000212	0.00143	CcSEcCtD
Carvedilol—Hyperhidrosis—Pentoxifylline—malaria	0.000212	0.00142	CcSEcCtD
Carvedilol—Vomiting—Sulfadiazine—malaria	0.000211	0.00142	CcSEcCtD
Carvedilol—Decreased appetite—Quinidine—malaria	0.000211	0.00142	CcSEcCtD
Carvedilol—Decreased appetite—Quinine—malaria	0.000211	0.00142	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Quinine—malaria	0.00021	0.00141	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Quinidine—malaria	0.00021	0.00141	CcSEcCtD
Carvedilol—Rash—Sulfadiazine—malaria	0.00021	0.00141	CcSEcCtD
Carvedilol—Dermatitis—Sulfadiazine—malaria	0.000209	0.00141	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dapsone—malaria	0.000209	0.00141	CcSEcCtD
Carvedilol—ADRA1A—brain—malaria	0.000209	0.00195	CbGeAlD
Carvedilol—Anorexia—Quinidine barbiturate—malaria	0.000209	0.00141	CcSEcCtD
Carvedilol—Anorexia—Pentoxifylline—malaria	0.000209	0.0014	CcSEcCtD
Carvedilol—CYP2D6—digestive system—malaria	0.000208	0.00194	CbGeAlD
Carvedilol—Headache—Sulfadiazine—malaria	0.000208	0.0014	CcSEcCtD
Carvedilol—CYP2C9—liver—malaria	0.000207	0.00193	CbGeAlD
Carvedilol—Hypotension—Quinidine barbiturate—malaria	0.000205	0.00138	CcSEcCtD
Carvedilol—Hypotension—Pentoxifylline—malaria	0.000204	0.00138	CcSEcCtD
Carvedilol—Gastrointestinal pain—Clindamycin—malaria	0.000202	0.00136	CcSEcCtD
Carvedilol—Body temperature increased—Dapsone—malaria	0.000202	0.00136	CcSEcCtD
Carvedilol—Abdominal pain—Dapsone—malaria	0.000202	0.00136	CcSEcCtD
Carvedilol—KCNH2—brain—malaria	0.000202	0.00188	CbGeAlD
Carvedilol—CYP3A4—blood—malaria	0.000202	0.00188	CbGeAlD
Carvedilol—Feeling abnormal—Quinidine—malaria	0.0002	0.00135	CcSEcCtD
Carvedilol—Feeling abnormal—Quinine—malaria	0.0002	0.00135	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.0002	0.00135	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000199	0.00134	CcSEcCtD
Carvedilol—ADRA2C—brain—malaria	0.000199	0.00186	CbGeAlD
Carvedilol—Gastrointestinal pain—Quinine—malaria	0.000199	0.00134	CcSEcCtD
Carvedilol—Gastrointestinal pain—Quinidine—malaria	0.000199	0.00134	CcSEcCtD
Carvedilol—CYP2D6—blood—malaria	0.000199	0.00185	CbGeAlD
Carvedilol—Insomnia—Pentoxifylline—malaria	0.000198	0.00133	CcSEcCtD
Carvedilol—Nausea—Sulfadiazine—malaria	0.000198	0.00133	CcSEcCtD
Carvedilol—Urticaria—Clindamycin—malaria	0.000197	0.00132	CcSEcCtD
Carvedilol—CYP2E1—liver—malaria	0.000196	0.00183	CbGeAlD
Carvedilol—Abdominal pain—Clindamycin—malaria	0.000196	0.00132	CcSEcCtD
Carvedilol—Body temperature increased—Clindamycin—malaria	0.000196	0.00132	CcSEcCtD
Carvedilol—Dyspnoea—Quinidine barbiturate—malaria	0.000195	0.00132	CcSEcCtD
Carvedilol—Dyspnoea—Pentoxifylline—malaria	0.000195	0.00131	CcSEcCtD
Carvedilol—Somnolence—Quinidine barbiturate—malaria	0.000195	0.00131	CcSEcCtD
Carvedilol—Somnolence—Pentoxifylline—malaria	0.000195	0.00131	CcSEcCtD
Carvedilol—Urticaria—Quinine—malaria	0.000193	0.0013	CcSEcCtD
Carvedilol—Urticaria—Quinidine—malaria	0.000193	0.0013	CcSEcCtD
Carvedilol—Dyspepsia—Pentoxifylline—malaria	0.000193	0.0013	CcSEcCtD
Carvedilol—Abdominal pain—Quinidine—malaria	0.000192	0.00129	CcSEcCtD
Carvedilol—Body temperature increased—Quinidine—malaria	0.000192	0.00129	CcSEcCtD
Carvedilol—Body temperature increased—Quinine—malaria	0.000192	0.00129	CcSEcCtD
Carvedilol—Abdominal pain—Quinine—malaria	0.000192	0.00129	CcSEcCtD
Carvedilol—Decreased appetite—Quinidine barbiturate—malaria	0.000191	0.00128	CcSEcCtD
Carvedilol—Decreased appetite—Pentoxifylline—malaria	0.00019	0.00128	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000189	0.00127	CcSEcCtD
Carvedilol—Pain—Quinidine barbiturate—malaria	0.000187	0.00126	CcSEcCtD
Carvedilol—Constipation—Quinidine barbiturate—malaria	0.000187	0.00126	CcSEcCtD
Carvedilol—Constipation—Pentoxifylline—malaria	0.000187	0.00126	CcSEcCtD
Carvedilol—Hypersensitivity—Clindamycin—malaria	0.000182	0.00123	CcSEcCtD
Carvedilol—Feeling abnormal—Quinidine barbiturate—malaria	0.000181	0.00122	CcSEcCtD
Carvedilol—Feeling abnormal—Pentoxifylline—malaria	0.00018	0.00121	CcSEcCtD
Carvedilol—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000179	0.00121	CcSEcCtD
Carvedilol—Hypersensitivity—Quinine—malaria	0.000179	0.00121	CcSEcCtD
Carvedilol—Hypersensitivity—Quinidine—malaria	0.000179	0.00121	CcSEcCtD
Carvedilol—Gastrointestinal pain—Pentoxifylline—malaria	0.000179	0.00121	CcSEcCtD
Carvedilol—Asthenia—Clindamycin—malaria	0.000178	0.0012	CcSEcCtD
Carvedilol—ABCB1—kidney—malaria	0.000177	0.00164	CbGeAlD
Carvedilol—Pruritus—Clindamycin—malaria	0.000175	0.00118	CcSEcCtD
Carvedilol—Asthenia—Quinidine—malaria	0.000174	0.00117	CcSEcCtD
Carvedilol—Asthenia—Quinine—malaria	0.000174	0.00117	CcSEcCtD
Carvedilol—Urticaria—Quinidine barbiturate—malaria	0.000174	0.00117	CcSEcCtD
Carvedilol—Urticaria—Pentoxifylline—malaria	0.000174	0.00117	CcSEcCtD
Carvedilol—Abdominal pain—Quinidine barbiturate—malaria	0.000173	0.00117	CcSEcCtD
Carvedilol—Body temperature increased—Quinidine barbiturate—malaria	0.000173	0.00117	CcSEcCtD
Carvedilol—Abdominal pain—Pentoxifylline—malaria	0.000173	0.00117	CcSEcCtD
Carvedilol—Body temperature increased—Pentoxifylline—malaria	0.000173	0.00117	CcSEcCtD
Carvedilol—Pruritus—Quinidine—malaria	0.000172	0.00116	CcSEcCtD
Carvedilol—Pruritus—Quinine—malaria	0.000172	0.00116	CcSEcCtD
Carvedilol—CYP1A1—brain—malaria	0.000171	0.00159	CbGeAlD
Carvedilol—Diarrhoea—Clindamycin—malaria	0.000169	0.00114	CcSEcCtD
Carvedilol—Diarrhoea—Quinidine—malaria	0.000166	0.00112	CcSEcCtD
Carvedilol—Diarrhoea—Quinine—malaria	0.000166	0.00112	CcSEcCtD
Carvedilol—Dizziness—Clindamycin—malaria	0.000164	0.0011	CcSEcCtD
Carvedilol—Vomiting—Dapsone—malaria	0.000163	0.0011	CcSEcCtD
Carvedilol—Hypersensitivity—Quinidine barbiturate—malaria	0.000162	0.00109	CcSEcCtD
Carvedilol—Hypersensitivity—Pentoxifylline—malaria	0.000161	0.00109	CcSEcCtD
Carvedilol—Dizziness—Quinine—malaria	0.000161	0.00108	CcSEcCtD
Carvedilol—Dizziness—Quinidine—malaria	0.000161	0.00108	CcSEcCtD
Carvedilol—Headache—Dapsone—malaria	0.00016	0.00108	CcSEcCtD
Carvedilol—ADRA2A—brain—malaria	0.000159	0.00148	CbGeAlD
Carvedilol—CYP3A4—liver—malaria	0.000158	0.00147	CbGeAlD
Carvedilol—Vomiting—Clindamycin—malaria	0.000157	0.00106	CcSEcCtD
Carvedilol—Asthenia—Quinidine barbiturate—malaria	0.000157	0.00106	CcSEcCtD
Carvedilol—Asthenia—Pentoxifylline—malaria	0.000157	0.00106	CcSEcCtD
Carvedilol—Rash—Clindamycin—malaria	0.000156	0.00105	CcSEcCtD
Carvedilol—Dermatitis—Clindamycin—malaria	0.000156	0.00105	CcSEcCtD
Carvedilol—CYP2E1—brain—malaria	0.000156	0.00145	CbGeAlD
Carvedilol—CYP2D6—liver—malaria	0.000155	0.00145	CbGeAlD
Carvedilol—Headache—Clindamycin—malaria	0.000155	0.00104	CcSEcCtD
Carvedilol—Pruritus—Quinidine barbiturate—malaria	0.000155	0.00104	CcSEcCtD
Carvedilol—Pruritus—Pentoxifylline—malaria	0.000155	0.00104	CcSEcCtD
Carvedilol—Vomiting—Quinine—malaria	0.000154	0.00104	CcSEcCtD
Carvedilol—Vomiting—Quinidine—malaria	0.000154	0.00104	CcSEcCtD
Carvedilol—Rash—Quinidine—malaria	0.000153	0.00103	CcSEcCtD
Carvedilol—Rash—Quinine—malaria	0.000153	0.00103	CcSEcCtD
Carvedilol—Dermatitis—Quinine—malaria	0.000153	0.00103	CcSEcCtD
Carvedilol—Dermatitis—Quinidine—malaria	0.000153	0.00103	CcSEcCtD
Carvedilol—Headache—Quinine—malaria	0.000152	0.00102	CcSEcCtD
Carvedilol—Headache—Quinidine—malaria	0.000152	0.00102	CcSEcCtD
Carvedilol—Nausea—Dapsone—malaria	0.000152	0.00102	CcSEcCtD
Carvedilol—Diarrhoea—Quinidine barbiturate—malaria	0.00015	0.00101	CcSEcCtD
Carvedilol—ABCB1—digestive system—malaria	0.00015	0.0014	CbGeAlD
Carvedilol—PTGS1—brain—malaria	0.00015	0.0014	CbGeAlD
Carvedilol—Diarrhoea—Pentoxifylline—malaria	0.00015	0.00101	CcSEcCtD
Carvedilol—Nausea—Clindamycin—malaria	0.000147	0.000991	CcSEcCtD
Carvedilol—Dizziness—Quinidine barbiturate—malaria	0.000145	0.000976	CcSEcCtD
Carvedilol—Dizziness—Pentoxifylline—malaria	0.000145	0.000975	CcSEcCtD
Carvedilol—Nausea—Quinine—malaria	0.000144	0.000972	CcSEcCtD
Carvedilol—Nausea—Quinidine—malaria	0.000144	0.000972	CcSEcCtD
Carvedilol—ABCB1—blood—malaria	0.000143	0.00133	CbGeAlD
Carvedilol—Vomiting—Quinidine barbiturate—malaria	0.000139	0.000939	CcSEcCtD
Carvedilol—Vomiting—Pentoxifylline—malaria	0.000139	0.000937	CcSEcCtD
Carvedilol—Rash—Quinidine barbiturate—malaria	0.000138	0.000931	CcSEcCtD
Carvedilol—ABCB1—bone marrow—malaria	0.000138	0.00129	CbGeAlD
Carvedilol—Dermatitis—Quinidine barbiturate—malaria	0.000138	0.00093	CcSEcCtD
Carvedilol—Rash—Pentoxifylline—malaria	0.000138	0.000929	CcSEcCtD
Carvedilol—Dermatitis—Pentoxifylline—malaria	0.000138	0.000928	CcSEcCtD
Carvedilol—Headache—Quinidine barbiturate—malaria	0.000137	0.000925	CcSEcCtD
Carvedilol—Headache—Pentoxifylline—malaria	0.000137	0.000923	CcSEcCtD
Carvedilol—Nausea—Quinidine barbiturate—malaria	0.00013	0.000877	CcSEcCtD
Carvedilol—Nausea—Pentoxifylline—malaria	0.00013	0.000875	CcSEcCtD
Carvedilol—CYP2D6—brain—malaria	0.000123	0.00115	CbGeAlD
Carvedilol—ABCB1—liver—malaria	0.000112	0.00104	CbGeAlD
Carvedilol—ABCB1—brain—malaria	8.86e-05	0.000825	CbGeAlD
Carvedilol—ADRB3—Signaling Pathways—ACKR1—malaria	4.29e-05	0.000499	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—ACKR1—malaria	4.29e-05	0.000498	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—ACKR1—malaria	4.28e-05	0.000497	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—TNF—malaria	4.26e-05	0.000495	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	4.23e-05	0.000492	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—ACKR1—malaria	4.22e-05	0.00049	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—malaria	4.18e-05	0.000485	CbGpPWpGaD
Carvedilol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	4.15e-05	0.000483	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—DHODH—malaria	4.15e-05	0.000482	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—DHODH—malaria	4.14e-05	0.000481	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—KDR—malaria	4.13e-05	0.00048	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.07e-05	0.000473	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—CD36—malaria	4.07e-05	0.000473	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IFNG—malaria	4.06e-05	0.000471	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IFNG—malaria	4.04e-05	0.00047	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—ACKR1—malaria	3.99e-05	0.000464	CbGpPWpGaD
Carvedilol—VEGFA—SIDS Susceptibility Pathways—IL6—malaria	3.96e-05	0.00046	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—ACKR1—malaria	3.93e-05	0.000457	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD4—malaria	3.92e-05	0.000455	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	3.91e-05	0.000454	CbGpPWpGaD
Carvedilol—XDH—Metabolism—HPGDS—malaria	3.88e-05	0.00045	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—NOS2—malaria	3.86e-05	0.000448	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.74e-05	0.000435	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—HPGDS—malaria	3.68e-05	0.000427	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IL1B—malaria	3.62e-05	0.00042	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL1B—malaria	3.61e-05	0.000419	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IL2—malaria	3.61e-05	0.000419	CbGpPWpGaD
Carvedilol—XDH—Metabolism—DHFR—malaria	3.6e-05	0.000418	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—IL6—malaria	3.59e-05	0.000417	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL2—malaria	3.59e-05	0.000417	CbGpPWpGaD
Carvedilol—XDH—Metabolism—SCARB1—malaria	3.56e-05	0.000413	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC4A1—malaria	3.53e-05	0.00041	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC4A1—malaria	3.52e-05	0.000409	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—ACKR1—malaria	3.49e-05	0.000406	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TLR9—malaria	3.46e-05	0.000402	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TLR9—malaria	3.45e-05	0.000401	CbGpPWpGaD
Carvedilol—PTGS1—Selenium Micronutrient Network—IL6—malaria	3.44e-05	0.0004	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—DHODH—malaria	3.37e-05	0.000392	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	3.34e-05	0.000388	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—DECR1—malaria	3.32e-05	0.000385	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—DECR1—malaria	3.31e-05	0.000385	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—ACKR1—malaria	3.24e-05	0.000377	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	3.22e-05	0.000374	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	3.22e-05	0.000374	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CD4—malaria	3.21e-05	0.000372	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—KDR—malaria	3.19e-05	0.00037	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—DHODH—malaria	3.1e-05	0.00036	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.04e-05	0.000353	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—IL2—malaria	3.01e-05	0.000349	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—HBB—malaria	3e-05	0.000349	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—HBB—malaria	3e-05	0.000348	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—DHODH—malaria	2.92e-05	0.000339	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.87e-05	0.000333	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC4A1—malaria	2.87e-05	0.000333	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—IL2—malaria	2.81e-05	0.000326	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ACKR1—malaria	2.8e-05	0.000325	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—CD36—malaria	2.77e-05	0.000321	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—DECR1—malaria	2.7e-05	0.000313	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PKLR—malaria	2.67e-05	0.000311	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PKLR—malaria	2.67e-05	0.00031	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.64e-05	0.000306	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC4A1—malaria	2.63e-05	0.000306	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—IL2—malaria	2.63e-05	0.000305	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—TNF—malaria	2.62e-05	0.000304	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—IL6—malaria	2.6e-05	0.000302	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—CD36—malaria	2.58e-05	0.0003	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ACKR1—malaria	2.55e-05	0.000296	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ACKR1—malaria	2.53e-05	0.000293	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ACKR1—malaria	2.49e-05	0.00029	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC4A1—malaria	2.48e-05	0.000288	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—DECR1—malaria	2.48e-05	0.000288	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—HBB—malaria	2.44e-05	0.000283	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—G6PD—malaria	2.38e-05	0.000277	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—G6PD—malaria	2.38e-05	0.000276	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ACKR1—malaria	2.36e-05	0.000274	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.35e-05	0.000273	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—DECR1—malaria	2.33e-05	0.000271	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—DHODH—malaria	2.33e-05	0.000271	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ACKR1—malaria	2.32e-05	0.00027	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—IL2—malaria	2.28e-05	0.000265	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—NOS2—malaria	2.27e-05	0.000264	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TLR9—malaria	2.25e-05	0.000262	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—HBB—malaria	2.24e-05	0.00026	CbGpPWpGaD
Carvedilol—XDH—Metabolism—CD36—malaria	2.23e-05	0.000259	CbGpPWpGaD
Carvedilol—VEGFA—Axon guidance—IL6—malaria	2.21e-05	0.000256	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—DHODH—malaria	2.2e-05	0.000255	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—DHODH—malaria	2.18e-05	0.000253	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PKLR—malaria	2.17e-05	0.000252	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.14e-05	0.000249	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—NOS2—malaria	2.12e-05	0.000247	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—IL6—malaria	2.12e-05	0.000246	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—HBB—malaria	2.11e-05	0.000245	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—CD36—malaria	2.1e-05	0.000244	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL2—malaria	2.07e-05	0.00024	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ACKR1—malaria	2.06e-05	0.00024	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TLR9—malaria	2.05e-05	0.000239	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TLR9—malaria	2.04e-05	0.000236	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TLR9—malaria	2.01e-05	0.000233	CbGpPWpGaD
Carvedilol—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	2e-05	0.000232	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PKLR—malaria	2e-05	0.000232	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC4A1—malaria	1.98e-05	0.00023	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.97e-05	0.000228	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—TNF—malaria	1.95e-05	0.000227	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—G6PD—malaria	1.94e-05	0.000225	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ACKR1—malaria	1.92e-05	0.000223	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TLR9—malaria	1.9e-05	0.000221	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PKLR—malaria	1.88e-05	0.000218	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TLR9—malaria	1.87e-05	0.000217	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC4A1—malaria	1.87e-05	0.000217	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—DECR1—malaria	1.86e-05	0.000217	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DHODH—malaria	1.86e-05	0.000216	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC4A1—malaria	1.85e-05	0.000215	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.83e-05	0.000213	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—HPGDS—malaria	1.82e-05	0.000211	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—HPGDS—malaria	1.81e-05	0.000211	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—G6PD—malaria	1.78e-05	0.000207	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—DECR1—malaria	1.76e-05	0.000204	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—DECR1—malaria	1.74e-05	0.000202	CbGpPWpGaD
Carvedilol—HIF1A—Disease—IL6—malaria	1.73e-05	0.000201	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—NOS2—malaria	1.73e-05	0.0002	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—DHFR—malaria	1.69e-05	0.000196	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HBB—malaria	1.69e-05	0.000196	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—DHFR—malaria	1.68e-05	0.000196	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.68e-05	0.000195	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—G6PD—malaria	1.68e-05	0.000195	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SCARB1—malaria	1.67e-05	0.000194	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SCARB1—malaria	1.67e-05	0.000194	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—IL2—malaria	1.67e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TLR9—malaria	1.66e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	1.66e-05	0.000193	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.65e-05	0.000192	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HBB—malaria	1.59e-05	0.000185	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC4A1—malaria	1.58e-05	0.000184	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—IL6—malaria	1.58e-05	0.000183	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HBB—malaria	1.57e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—IL2—malaria	1.55e-05	0.00018	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TLR9—malaria	1.54e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL2—malaria	1.51e-05	0.000176	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PKLR—malaria	1.5e-05	0.000175	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DECR1—malaria	1.49e-05	0.000173	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—HPGDS—malaria	1.48e-05	0.000172	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	1.48e-05	0.000171	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—IL2—malaria	1.45e-05	0.000168	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DHODH—malaria	1.44e-05	0.000167	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PKLR—malaria	1.42e-05	0.000164	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PKLR—malaria	1.4e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—KDR—malaria	1.38e-05	0.00016	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—KDR—malaria	1.38e-05	0.00016	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—DHFR—malaria	1.37e-05	0.000159	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—HPGDS—malaria	1.36e-05	0.000158	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SCARB1—malaria	1.36e-05	0.000158	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HBB—malaria	1.35e-05	0.000156	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—G6PD—malaria	1.34e-05	0.000156	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.29e-05	0.00015	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—HPGDS—malaria	1.28e-05	0.000149	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—G6PD—malaria	1.26e-05	0.000147	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—DHFR—malaria	1.26e-05	0.000146	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—G6PD—malaria	1.25e-05	0.000145	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SCARB1—malaria	1.25e-05	0.000145	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.23e-05	0.000143	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC4A1—malaria	1.22e-05	0.000142	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL6—malaria	1.21e-05	0.000141	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PKLR—malaria	1.2e-05	0.000139	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—DHFR—malaria	1.19e-05	0.000138	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—IL2—malaria	1.18e-05	0.000137	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SCARB1—malaria	1.17e-05	0.000136	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DECR1—malaria	1.15e-05	0.000133	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—IL2—malaria	1.08e-05	0.000126	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—G6PD—malaria	1.07e-05	0.000124	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.05e-05	0.000123	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CD36—malaria	1.05e-05	0.000122	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CD36—malaria	1.05e-05	0.000121	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HBB—malaria	1.04e-05	0.000121	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HPGDS—malaria	1.02e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—malaria	9.88e-06	0.000115	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—malaria	9.85e-06	0.000114	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—malaria	9.79e-06	0.000114	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—malaria	9.67e-06	0.000112	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HPGDS—malaria	9.62e-06	0.000112	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HPGDS—malaria	9.54e-06	0.000111	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—DHFR—malaria	9.47e-06	0.00011	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SCARB1—malaria	9.38e-06	0.000109	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PKLR—malaria	9.26e-06	0.000108	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—malaria	9.15e-06	0.000106	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—malaria	9e-06	0.000105	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—KDR—malaria	8.98e-06	0.000104	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—malaria	8.98e-06	0.000104	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—malaria	8.93e-06	0.000104	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—DHFR—malaria	8.93e-06	0.000104	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—malaria	8.91e-06	0.000104	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—malaria	8.89e-06	0.000103	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—malaria	8.89e-06	0.000103	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—DHFR—malaria	8.85e-06	0.000103	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SCARB1—malaria	8.84e-06	0.000103	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—malaria	8.78e-06	0.000102	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SCARB1—malaria	8.76e-06	0.000102	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CD36—malaria	8.51e-06	9.88e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—malaria	8.31e-06	9.65e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—G6PD—malaria	8.25e-06	9.58e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—KDR—malaria	8.18e-06	9.5e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—malaria	8.18e-06	9.5e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HPGDS—malaria	8.15e-06	9.47e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—KDR—malaria	8.1e-06	9.41e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—KDR—malaria	8e-06	9.29e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—malaria	8e-06	9.29e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CD36—malaria	7.81e-06	9.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KDR—malaria	7.57e-06	8.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DHFR—malaria	7.56e-06	8.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SCARB1—malaria	7.48e-06	8.69e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KDR—malaria	7.45e-06	8.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—malaria	7.43e-06	8.63e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CD36—malaria	7.37e-06	8.56e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—malaria	7.26e-06	8.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—malaria	6.75e-06	7.84e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KDR—malaria	6.62e-06	7.69e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HPGDS—malaria	6.29e-06	7.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KDR—malaria	6.15e-06	7.14e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CD36—malaria	5.88e-06	6.83e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DHFR—malaria	5.84e-06	6.78e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—malaria	5.82e-06	6.76e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—malaria	5.79e-06	6.73e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SCARB1—malaria	5.78e-06	6.71e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CD36—malaria	5.54e-06	6.44e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CD36—malaria	5.5e-06	6.39e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—malaria	5.3e-06	6.16e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—malaria	5.28e-06	6.13e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—malaria	5.25e-06	6.1e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—malaria	5.25e-06	6.1e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—malaria	5.24e-06	6.09e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—malaria	5.23e-06	6.07e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—malaria	5.19e-06	6.03e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—malaria	5.16e-06	6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—malaria	4.91e-06	5.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—malaria	4.88e-06	5.67e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—malaria	4.83e-06	5.61e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—malaria	4.81e-06	5.58e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CD36—malaria	4.7e-06	5.46e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—malaria	4.29e-06	4.98e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—malaria	4.27e-06	4.96e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—malaria	3.99e-06	4.63e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—malaria	3.97e-06	4.61e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CD36—malaria	3.63e-06	4.21e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—malaria	3.42e-06	3.97e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—malaria	3.12e-06	3.62e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—malaria	3.09e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—malaria	3.05e-06	3.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—malaria	2.88e-06	3.35e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—malaria	2.84e-06	3.3e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—malaria	2.52e-06	2.93e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—malaria	2.34e-06	2.72e-05	CbGpPWpGaD
